MannKind Corporation

MannKind Corporation - PE Ratioverified

MNKD

Price:

$3.94

Market Cap:

$1.22B

MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, ...[Read more]

Industry

Biotechnology

IPO Date

2004-07-28

Stock Exchange

NASDAQ

Ticker

MNKD

The PE Ratio as of June 2026 (TTM) for MannKind Corporation (MNKD) is -56.29

According to MannKind Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -56.29. This represents a change of -151.43% compared to the average of 109.45 of the last 4 quarters.

MannKind Corporation (MNKD) Historical PE Ratio (quarterly & annually)

How has MNKD PE Ratio performed in the past?

The mean historical PE Ratio of MannKind Corporation over the last ten years is 22.49. The current -56.29 PE Ratio has changed -25130.64% with respect to the historical average. Over the past ten years (40 quarters), MNKD's PE Ratio was at its highest in in the June 2025 quarter at 425.00. The PE Ratio was at its lowest in in the June 2024 quarter at -171.96.

Quarterly (TTM)
Annual

Average

22.49

Median

-3.11

Minimum

-81.43

Maximum

283.50

MannKind Corporation (MNKD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of MannKind Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 579.89%

Maximum Annual PE Ratio = 283.50

Minimum Annual Increase = -245.51%

Minimum Annual PE Ratio = -81.43

Quarterly (TTM)
Annual
YearPE RatioChange
2025283.50340.90%
202464.30-178.96%
2023-81.43579.89%
2022-11.981.41%
2021-11.81-1.89%
2020-12.04189.30%
2019-4.16135.54%
2018-1.77-13.95%
2017-2.05-188.35%
20162.32-245.51%

MannKind Corporation (MNKD) Average PE Ratio

How has MNKD PE Ratio performed in the past?

The current PE Ratio of MannKind Corporation (MNKD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

88.79

5-year avg

48.52

10-year avg

22.49

MannKind Corporation (MNKD) PE Ratio vs. Peers

How is MNKD’s PE Ratio compared to its peers?

MannKind Corporation’s PE Ratio is less than Aurinia Pharmaceuticals Inc. (7.35), less than Harmony Biosciences Holdings, Inc. (13.21), less than Celldex Therapeutics, Inc. (-7.59), less than Vera Therapeutics, Inc. (-6.33), less than Janux Therapeutics, Inc. (-7.73), less than AbCellera Biologics Inc. (-11.52), less than Nuvation Bio Inc. (-13.10), greater than Immunocore Holdings plc (-76.39), less than Biohaven Ltd. (-2.39), less than Sionna Therapeutics, Inc. (-19.33),

Build a custom stock screener for MannKind Corporation (MNKD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MannKind Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MannKind Corporation (MNKD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MannKind Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is MannKind Corporation's PE Ratio?

How is the PE Ratio calculated for MannKind Corporation (MNKD)?

What is the highest PE Ratio for MannKind Corporation (MNKD)?

What is the 3-year average PE Ratio for MannKind Corporation (MNKD)?

What is the 5-year average PE Ratio for MannKind Corporation (MNKD)?

How does the current PE Ratio for MannKind Corporation (MNKD) compare to its historical average?